Melissa Angelini - Procaps Group Investor Director

PROCW Stock  USD 0.01  0  8.03%   

Director

Melissa Angelini is Investor Director of Procaps Group SA
Address 9 Rue de Bitbourg, Luxembourg, Luxembourg, 1273
Phone356 7995 6138
Webhttps://www.procapsgroup.com

Procaps Group Management Efficiency

The company has return on total asset (ROA) of 0.0628 % which means that it generated a profit of $0.0628 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.3737 %, meaning that it generated $0.3737 on every $100 dollars invested by stockholders. Procaps Group's management efficiency ratios could be used to measure how well Procaps Group manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Procaps Group's Return On Tangible Assets are fairly stable compared to the past year. Return On Assets is likely to climb to 0.09 in 2024, whereas Return On Capital Employed is likely to drop 0.41 in 2024. At this time, Procaps Group's Return On Tangible Assets are fairly stable compared to the past year. Intangibles To Total Assets is likely to climb to 0.1 in 2024, whereas Non Current Assets Total are likely to drop slightly above 133.4 M in 2024.

Similar Executives

Found 10 records

DIRECTOR Age

Thomas RossBausch Health Companies
69
Russel RobertsonBausch Health Companies
72
Dawn AllenHaleon plc
56
Andrew EschenbachBausch Health Companies
78
Robert PowerBausch Health Companies
63
John PaulsonBausch Health Companies
64
Argeris KarabelasBausch Health Companies
66
Richard SchutterBausch Health Companies
79
Amy WechslerBausch Health Companies
50
Sarah KavanaghBausch Health Companies
63
Procaps Group, S.A. develops, manufactures, and markets over-the-counter and prescription drugs, nutritional supplements, and clinical solutions. The company was founded in 1977 and is based in Luxembourg City, Luxembourg Procaps Group is traded on NASDAQ Exchange in the United States. Procaps Group SA (PROCW) is traded on NASDAQ Exchange in USA. It is located in 9 Rue de Bitbourg, Luxembourg, Luxembourg, 1273 and employs 5,500 people. Procaps Group is listed under Biotechnology category by Fama And French industry classification.

Management Performance

Procaps Group SA Leadership Team

Elected by the shareholders, the Procaps Group's board of directors comprises two types of representatives: Procaps Group inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Procaps. The board's role is to monitor Procaps Group's management team and ensure that shareholders' interests are well served. Procaps Group's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Procaps Group's outside directors are responsible for providing unbiased perspectives on the board's policies.
Camilo Camacho, Chief Officer
Sergio Gomez, Chief Officer
Patricio Vargas, Global Officer
Marcela Pagano, VicePresident Affairs
Ruben Minski, Founder Chairman
Carlos Russo, Head Finance
Luis Aragon, VicePresident RD
Jose Vieira, Chief Officer
Mauricio Caballero, VicePresident Resources
Melissa Angelini, Investor Director
Patricio Munoz, Global Officer

Procaps Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Procaps Group a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Procaps Stock Analysis

When running Procaps Group's price analysis, check to measure Procaps Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Procaps Group is operating at the current time. Most of Procaps Group's value examination focuses on studying past and present price action to predict the probability of Procaps Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Procaps Group's price. Additionally, you may evaluate how the addition of Procaps Group to your portfolios can decrease your overall portfolio volatility.